Core Viewpoint - Ningbo Jianxin Superconductor Technology Co., Ltd. officially listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board, marking a new chapter in its capital market journey [1] Company Overview - Jianxin Superconductor issued 41.92 million shares, raising a net amount of 689 million yuan, which will be primarily invested in the production of 600 sets of helium-free superconducting magnets and high-field medical superconducting magnets, as well as R&D of new superconducting magnets [2] - Established in 2013, the company focuses on the R&D, production, and sales of core components for MRI equipment, with key products including superconducting magnets, permanent magnets, and gradient coils, which account for approximately 50% of MRI equipment costs [2] Product and Technology - The company's 1.5T helium-free superconducting magnet utilizes solid-state conduction cooling technology, eliminating the need for liquid helium, addressing supply shortages, and enhancing reliability and adaptability of MRI equipment [3] - As of June 30, 2025, the company holds 85 authorized patents, including 45 invention patents, and has developed 13 core technologies with independent intellectual property rights [3] Financial Performance - Jianxin Superconductor has shown a growth trend in revenue, achieving 359 million yuan, 451 million yuan, and 425 million yuan in revenue for the years 2022 to 2024, with corresponding net profits of 34.63 million yuan, 48.73 million yuan, and 55.78 million yuan [4] - For the first nine months of 2025, the company reported revenue of 393 million yuan, a year-on-year increase of 37.34%, and a net profit of 47.62 million yuan, up 38.54% year-on-year [4] - The company projects 2025 revenue to reach between 580 million yuan and 620 million yuan, with a year-on-year growth of 36.31% to 45.71%, and net profit expected to be between 70 million yuan and 75 million yuan, reflecting a growth of 39.25% to 49.20% [4] Market Context - The demand for medical MRI equipment in China is significant, as the density of MRI devices remains lower than in Europe and the United States, indicating a potential market opportunity [1] - Jianxin Superconductor's products align with the trends of helium-free, high-field, and open MRI systems, and the company has established partnerships with leading global MRI manufacturers [2]
健信超导上市首日涨幅212.81% 无液氦技术卡位医疗超导赛道